Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
125.96
-2.68 (-2.08%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 15.76 | 5.94 | 3.08 | 4.16 |
| Research & Development | 22.84 | 8.15 | 8.79 | 13.88 |
| Operating Expenses | 38.6 | 14.1 | 11.87 | 18.04 |
| Operating Income | -38.6 | -14.1 | -11.87 | -18.04 |
| Interest Expense | -5.82 | -4.32 | - | -10.36 |
| Interest & Investment Income | 2.59 | 0.64 | 6.27 | - |
| Other Non Operating Income (Expenses) | 0.12 | -0.76 | 1.2 | -0.17 |
| EBT Excluding Unusual Items | -41.72 | -18.53 | -4.41 | -28.58 |
| Other Unusual Items | - | 1.1 | 23.1 | - |
| Pretax Income | -41.72 | -17.43 | 18.69 | -28.58 |
| Income Tax Expense | - | - | - | -1.03 |
| Net Income | -41.72 | -17.43 | 18.69 | -27.55 |
| Preferred Dividends & Other Adjustments | - | - | 14.81 | - |
| Net Income to Common | -41.72 | -17.43 | 3.88 | -27.55 |
| Shares Outstanding (Basic) | 11 | 2 | 2 | 6 |
| Shares Outstanding (Diluted) | 11 | 2 | 2 | 6 |
| Shares Change (YoY) | 405.46% | 24.08% | -68.63% | - |
| EPS (Basic) | -3.71 | -7.83 | 2.19 | -4.82 |
| EPS (Diluted) | -3.71 | -7.83 | 2.17 | -4.82 |
| EBIT | -38.6 | -14.1 | -11.87 | -18.04 |
Source: S&P Capital IQ. Standard template.
Financial Sources.